| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.4 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.041 | 0.5 |